Effectiveness of Bezlotoxumab for Prevention of Recurrent Clostridioides difficile Infection Among Transplant Recipients

BACKGROUND: Bezlotoxumab significantly reduces the incidence of recurrent Clostridioides difficile infection (CDI); however, limited data are available in solid organ transplant (SOT) and hematopoietic cell transplant (HCT) recipients. METHODS: We conducted a single-center retrospective analysis com...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnson, Tanner M, Howard, Amanda H, Miller, Matthew A, Allen, Lorna L, Huang, Misha, Molina, Kyle C, Bajrovic, Valida
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8274359/
https://www.ncbi.nlm.nih.gov/pubmed/34262988
http://dx.doi.org/10.1093/ofid/ofab294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8274359/
https://www.ncbi.nlm.nih.gov/pubmed/34262988
http://dx.doi.org/10.1093/ofid/ofab294

Ejemplares similares